Hyperlipoproteinemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
* [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | * [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | ||
* [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | * [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | ||
===[[Hypertriglyceridemia medical therapy | Pharmacotherapy]]=== | |||
* [[Statins]] | |||
* [[Niacin]] | |||
* [[Fibrate]] | |||
* [[Omega-3 fatty acids]] | |||
==References== | ==References== | ||
Revision as of 14:52, 24 August 2012
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]